S&P 500
(0.31%) 5 115.71 points
Dow Jones
(0.31%) 38 357 points
Nasdaq
(0.34%) 15 982 points
Oil
(-0.88%) $83.11
Gas
(5.77%) $2.03
Gold
(0.38%) $2 356.20
Silver
(0.47%) $27.67
Platinum
(4.05%) $959.40
USD/EUR
(-0.23%) $0.933
USD/NOK
(-0.38%) $10.98
USD/GBP
(-0.54%) $0.796
USD/RUB
(1.69%) $93.43

リアルタイムの更新: Rapid Micro Biosystems, [RPID]

取引所: NASDAQ セクター: Healthcare 産業: Medical Devices
Upcoming Earnings Alert

4 days till quarter result
(bmo 2024-05-03)

Expected move: +/- 14.20%

最終更新日時30 4月 2024 @ 00:30

-0.53% $ 0.945

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 00:30):
Profile picture for Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia...

Stats
本日の出来高 12 926.00
平均出来高 40 941.00
時価総額 40.44M
EPS $0 ( 2024-03-01 )
次の収益日 ( $-0.290 ) 2024-05-03
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.770
ATR14 $0.00800 (0.85%)
Insider Trading
Date Person Action Amount type
2024-03-11 Wilson John J. Addington Sell 9 569 Class A Common Stock
2024-03-11 Vezina Victoria Sell 5 435 Class A Common Stock
2024-03-11 Wirtjes Sean M Sell 7 454 Class A Common Stock
2024-03-11 Spignesi Robert G. Jr. Sell 10 323 Class A Common Stock
2024-02-12 Wilson John J. Addington Sell 5 809 Class A Common Stock
INSIDER POWER
91.54
Last 96 transactions
Buy: 3 823 953 | Sell: 95 953

Rapid Micro Biosystems, 相関

10 最も正の相関
QLGN0.971
ARQQ0.97
LYEL0.967
WISA0.967
NKTX0.961
TOPS0.96
SLNH0.959
STRC0.959
GROM0.958
SWVL0.958
10 最も負の相関
NWFL-0.958
LRFC-0.958
PEBK-0.958
MNKD-0.955
NECB-0.946
LUNA-0.945
IVAC-0.944
GDNR-0.941
STAY-0.939
ALOR-0.937

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Rapid Micro Biosystems, 財務諸表

Annual 2023
収益: $22.52M
総利益: $-5.49M (-24.36 %)
EPS: $-1.220
FY 2023
収益: $22.52M
総利益: $-5.49M (-24.36 %)
EPS: $-1.220
FY 2022
収益: $17.13M
総利益: $-8.54M (-49.85 %)
EPS: $-1.430
FY 2021
収益: $23.23M
総利益: $-7.74M (-33.32 %)
EPS: $-1.901

Financial Reports:

No articles found.

Rapid Micro Biosystems,

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。